Skip to main content
Premium Trial:

Request an Annual Quote

At the Front, But…

In an editorial, the Guardian writes that the National Health Service has always been at the forefront of medical innovation, something that it is continuing with its plans to sequence some 100,000 patients. "At last the high hopes of gene sequencing may be translated into practical medicine," it says. "There is talk of genetics as a diagnostic tool, the development of personalized medicine, and new, precision-targeted drugs that would amount to a revolution in healthcare."

At the same time, it notes that this forward-thinking aspect is at odds with other images of the NHS and issues it faces, including a recent argument over ambulance response times.

"The genome project and the row over ambulance services are at two extremes," the Guardian notes. "What is the point, patients could be forgiven for asking, of transformative innovation at one end of the spectrum if, at the other, ambulances cannot get to the sick in time to save them?"

Still, the Guardian says that such a project could only be undertaken by an organization with the reach of the NHS, and it will keep UK at the leading edge of science. 

Filed under

The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.